B Vitamins and Magnetic Resonance Imaging–Detected Ischemic Brain Lesions in Patients With Recent Transient Ischemic Attack or Stroke: The VITAmins TO Prevent Stroke (VITATOPS) MRI-Substudy
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Background and Purpose—: Elevated concentrations of homocysteine are associated with cerebral small vessel disease (CSVD). b-vitamin supplementation with folate and vitamins b 12 and b 6 reduces homocysteine concentrations. In a substudy of the VITAmins TO Prevent Stroke (VITATOPS) trial, we assessed the hypothesis that the addition of once-daily supplements of b vitamins would reduce the progression of CSVD-related brain lesions. Methods—: A total of 359 patients with recent stroke or transient ischemic attack, who were randomly allocated to double-blind treatment with placebo or b vitamins, underwent brain MRI at randomization and after 2 years of b-vitamin supplementation. MR images were analyzed blinded to treatment allocation. Outcomes related to the prespecified hypothesis were progression of white matter hyperintensities and incident lacunes. We also explored the effect of b-vitamin supplementation on the incidence of other ischemic abnormalities. Results—: After 2 years of treatment with b vitamins or placebo, there was no significant difference in white matter hyperintensities volume change (0.08 vs 0.13cm 3 ; P =0.419) and incidence of lacunes (8.0% vs 5.9%, P =0.434; odds ratio=1.38). In a subanalysis of patients with MRI evidence of severe CSVD at baseline, b-vitamin supplementation was associated with a significant reduction in white matter hyperintensities volume change (0.3 vs 1.7cm 3 ; P =0.039). Conclusions—: Daily b-vitamin supplementation for 2 years did not significantly reduce the progression of brain lesions resulting from presumed CSVD in all patients with recent stroke or transient ischemic attack but may do so in the subgroup of patients with recent stroke or transient ischemic attack and severe CSVD. Clinical Trial Registration—: http://vitatops.highway1.com.au/ . Unique identifier: NCT00097669 and ISRCTN74743444.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Feigin, V. L., Lawes, C. M., Bennett, D. A., & Anderson, C. S. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00266-7 · Cited by 1,932
Debette, S., Beiser, A., DeCarli, C., Au, R., Himali, J. J., Kelly-Hayes, M., Romero, J. R., Kase, C. S., Wolf, P. A., & Seshadri, S. (2010) · Stroke · doi:10.1161/strokeaha.109.570044 · Cited by 508 · cited 1×
“Our finding may have important clinical implications because white matter abnormalities have been reported to predict disability and mortality in elderly people.(23,24) Larger trials in patients with MRI evidence for severe CSVD are required to confirm our results.”
Inzitari, D., Pracucci, G., Poggesi, A., Carlucci, G., Barkhof, F., Chabriat, H., Erkinjuntti, T., Fazekas, F., Ferro, J. M., Hennerici, M., et al. (2009) · BMJ · doi:10.1136/bmj.b2477 · Cited by 415
Self-citation
Research works printed but not linked: 20
- 10.1016/S0140-6736(99)00309-8 · DOI · Paper page
- 10.1161/01.STR.31.5.1069 · DOI · Paper page
- 10.1093/brain/awh023 · DOI · Paper page
- 10.1016/S1474-4422(03)00258-8 · DOI
- 10.1093/ajcn/82.4.806 · DOI · Paper page
- 10.1159/000047761 · DOI · Paper page
- 10.1111/j.1747-4949.2007.00111.x · DOI · Paper page
- 10.1161/01.STR.19.10.1285 · DOI · Paper page
- 10.1161/01.str.0000049766.26453.e9 · DOI · Paper page
- 10.1016/S0140-6736(03)13616-1 · DOI · Paper page
- 10.1177/197140099200500413 · DOI · Paper page
- 10.1002/ana.10111 · DOI · Paper page
- 10.1002/ana.10440 · DOI · Paper page
- 10.1001/archneur.59.5.787 · DOI · Paper page
- 10.1258/0007142991902547 · DOI · Paper page
- 10.1073/pnas.94.11.5923 · DOI · Paper page
- Wolf R, Schabitz FL, Fisher M, Pak HC. The N-methyl-D-aspartate antagonist CNS 1102 protects cerebral gray and white matter from ischemic injury following temporary focal ischemia in rats. Stroke. 2003;31:1709–1714
- 10.1161/STROKEAHA.111.637686 · DOI
- 10.1161/strokeaha.107.489112 · DOI · Paper page
- 10.1111/j.1365-2362.2004.01332.x · DOI
Cited by
Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging
Wardlaw, J. M., Smith, C., & Dichgans, M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70060-7 · Cited by 1,657
van der Flier, W. M., Skoog, I., Schneider, J. A., Pantoni, L., Mok, V., Chen, C. L. H., & Scheltens, P. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.3 · Cited by 594
Self-citationHomocysteine lowering interventions for preventing cardiovascular events
Martí-Carvajal, A. J., Solà, I., Lathyris, D., & Salanti, G. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006612.pub2 · Cited by 520
Update on cerebral small vessel disease: a dynamic whole-brain disease
Shi, Y., & Wardlaw, J. M. (2016) · Stroke and Vascular Neurology · doi:10.1136/svn-2016-000035 · Cited by 459
Smith, E. E., Saposnik, G., Biessels, G. J., Doubal, F. N., Fornage, M., Gorelick, P. B., Greenberg, S. M., Higashida, R. T., Kasner, S. E., & Seshadri, S. (2017) · Stroke · doi:10.1161/str.0000000000000116 · Cited by 404
Hankey, G. J. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70255-2 · Cited by 384
Self-citationInoue, Y., Shue, F., Bu, G., & Kanekiyo, T. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00640-5 · Cited by 329
Li, Q., Yang, Y., Reis, C., Tao, T., Li, W., Li, X., & Zhang, J. H. (2018) · Cell Transplantation · doi:10.1177/0963689718795148 · Cited by 320
Homocysteine-lowering interventions for preventing cardiovascular events
Martí-Carvajal, A. J., Solà, I., Lathyris, D., & Dayer, M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006612.pub5 · Cited by 275
Homocysteine-lowering interventions for preventing cardiovascular events
Martí-Carvajal, A. J., Solà, I., & Lathyris, D. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006612.pub4 · Cited by 113
CADASIL as a useful medical model and genetic form of vascular depression
Park, J. H., Jeon, B.-H., Lee, J. S., Newhouse, P. A., Taylor, W. D., Boyd, B. D., Kim, K. W., & Kim, M.-D. (2017) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2017.03.013 · Cited by 22
Metadata
- Authors
- Cavalieri, M., Schmidt, R., Chen, C., Mok, V., de Freitas, G. R., Song, S., Yi, Q., Ropele, S., Grazer, A., Homayoon, N., Enzinger, C., Loh, K., Wong, K. S. L., Wong, A., Xiong, Y., Chang, H. M., Wong, M. C., Fazekas, F., Eikelboom, J. W., & Hankey, G. J.
- Venue
- Stroke
- Published
- 2012-12
- Volume
- 43
- Issue
- 12
- Pages
- 3266-3270
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2117167194
- Cited by
- 85
- References
- 4
- FWCI
- 4.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.